Sisram Medical Ltd (HKG:1696)

Sisram Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	60.25	70.23	70.6	81.55	153.06	116.53
Short-Term Investments	-	2.18	0.7	9.95	4.9	2.56
Trading Asset Securities	1.75	1.75	-	-	-	-
Cash & Short-Term Investments	62.01	74.16	71.3	91.49	157.96	119.08
Cash Growth	-12.41%	4.01%	-22.07%	-42.08%	32.65%	7.91%
Accounts Receivable	87.85	80.76	83.46	80.38	69.88	46.5
Other Receivables	-	3.78	10.8	-	-	0.98
Receivables	87.85	84.54	94.25	80.38	69.88	47.48
Inventory	87.69	81.02	80.55	74.72	64.24	37.19
Prepaid Expenses	16.49	3.02	4.29	-	-	-
Other Current Assets	1.49	6.49	6.96	3.97	5.53	1.4
Total Current Assets	255.52	249.21	257.35	250.57	297.6	205.15
Property, Plant & Equipment	60.64	59.47	62.91	52.2	45.46	46.16
Long-Term Investments	7.9	7.92	6.16	16.41	7.17	0.17
Goodwill	126.92	126.92	126.92	111.18	111.18	111.18
Other Intangible Assets	139.06	142.54	136.07	45.29	51.22	53.28
Long-Term Accounts Receivable	28.01	26.55	12.91	13.05	12.55	10.62
Long-Term Deferred Tax Assets	10.12	9.62	9.94	7.25	4.7	5.05
Other Long-Term Assets	5.11	5.03	1.26	59.66	0.25	0.2
Total Assets	633.26	627.26	613.5	555.6	530.13	431.81
Accounts Payable	21.43	13.36	8	13.34	13.02	9.44
Accrued Expenses	-	43.36	41.13	39.56	39.6	20.39
Short-Term Debt	5.07	4.8	4.42	5.74	7.29	1.13
Current Portion of Long-Term Debt	-	-	-	-	-	0.38
Current Portion of Leases	5.26	4.41	4.72	2.88	3.09	2.82
Current Income Taxes Payable	5.47	8.88	4.92	1.83	4.06	-
Current Unearned Revenue	11.47	15.6	15.9	14.38	15.04	8.18
Other Current Liabilities	48.18	5.09	9.15	2.41	1.45	12.44
Total Current Liabilities	96.86	95.49	88.25	80.13	83.56	54.79
Long-Term Debt	-	-	-	-	-	0.18
Long-Term Leases	36.64	34	35.54	32.72	31.24	32.55
Long-Term Unearned Revenue	1.88	1.25	0.85	0.59	0.26	0.22
Long-Term Deferred Tax Liabilities	9.12	8.67	14.36	8.65	9.41	9.91
Other Long-Term Liabilities	1.06	1.74	3.76	0.24	0.32	0.46
Total Liabilities	145.56	142.47	143.98	123.38	126.51	99.92
Common Stock	1.33	1.33	1.33	1.33	1.33	1.25
Additional Paid-In Capital	-	323.07	323.07	321.53	319.87	240.77
Retained Earnings	-	171.77	156.33	135.63	104.25	76.82
Comprehensive Income & Other	465.05	-32.14	-28.42	-27.62	-23.26	13.05
Total Common Equity	466.39	464.03	452.31	430.87	402.18	331.89
Minority Interest	21.31	20.76	17.21	1.35	1.44	-
Shareholders' Equity	487.7	484.79	469.53	432.23	403.63	331.89
Total Liabilities & Equity	633.26	627.26	613.5	555.6	530.13	431.81
Total Debt	46.97	43.2	44.68	41.34	41.62	37.06
Net Cash (Debt)	15.04	30.95	26.62	50.15	116.34	82.02
Net Cash Growth	-42.24%	16.29%	-46.93%	-56.89%	41.85%	-16.44%
Net Cash Per Share	0.03	0.07	0.06	0.11	0.26	0.19
Filing Date Shares Outstanding	468.34	468.34	468.34	467.29	466.16	442.16
Total Common Shares Outstanding	468.34	468.34	468.34	467.29	466.16	442.16
Working Capital	158.66	153.73	169.1	170.44	214.04	150.36
Book Value Per Share	1.00	0.99	0.97	0.92	0.86	0.75
Tangible Book Value	200.41	194.57	189.33	274.4	239.78	167.43
Tangible Book Value Per Share	0.43	0.42	0.40	0.59	0.51	0.38
Machinery	-	21.75	20.42	17.64	13.15	9.35
Leasehold Improvements	-	17.44	16.04	9.9	9.77	9.6

Source: S&P Global Market Intelligence. Standard template. Financial Sources.